Modifier genes in cystic fibrosis

This publication has 56 references indexed in Scilit:

• Symptoms, lung function, and ?2-adrenoceptor polymorphisms in a birth cohort followed for 10 years
  Pediatric Pulmonology, 2004
• Primer on Medical Genomics: Part XII: Pharmacogenomics—General Principles With Cancer as a Model
  Mayo Clinic Proceedings, 2004
• Variation in a Repeat Sequence Determines Whether a Common Variant of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Is Pathogenic or Benign
  American Journal of Human Genetics, 2004
• Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events
  American Heart Journal, 2004
• Stimulation of औ2-Adrenergic Receptor Increases Cystic Fibrosis Transmembrane Conductance Regulator Expression in Human Airway Epithelial Cells through a cAMP/Protein Kinase A-independent Pathway
  Published by Elsevier ,2003
• Genes in the vicinity of CFTR modulate the cystic fibrosis phenotype in highly concordant or discordant F508del homozygous sib pairs
  Human Genetics, 2003
• Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput
  The Pharmacogenomics Journal, 2003
• Mannose‐binding lectin (MBL) therapy in an MBL‐deficient patient with severe cystic fibrosis lung disease
  Pediatric Pulmonology, 2002
• Apolipoprotein E Genetic Variation and Alzheimer’s Disease
  Dementia and Geriatric Cognitive Disorders, 1999
• The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis
  Journal of Hepatology, 1995